Serafin Andrew 4

What Happened

• Andrew Serafin, Chief Strategy Officer at Harmony Biosciences (HRMY), exercised/options-converted a total of 5,100 shares (2,500 on 2026-01-24 and 2,600 on 2026-01-25) reported at an exercise/conversion price of $0.00. To satisfy tax withholding, the issuer withheld 1,116 shares (Jan 24) and 1,126 shares (Jan 25) at $36.82 each, totaling $41,091 and $41,459 respectively (combined ~$82,550).
• The filing also reports awards of restricted stock units (RSUs) totaling 54,800 shares (42,600 and 12,200) on 2026-01-22, reported as derivative awards (no cash paid). The RSUs and option vesting are subject to multi-year schedules described in the footnotes.

Key Details

• Transaction dates and amounts:
  • 2026-01-22: RSU grants — 42,600 and 12,200 RSUs (acquired, $0.00; derivative awards).
  • 2026-01-24: Option exercise/conversion — 2,500 shares (exercise price $0.00); 1,116 shares withheld for taxes at $36.82 = $41,091.
  • 2026-01-25: Option exercise/conversion — 2,600 shares (exercise price $0.00); 1,126 shares withheld for taxes at $36.82 = $41,459.
• Net shares retained from exercises (after withholding): 5,100 exercised − 2,242 withheld = 2,858 net shares issued to the reporting person.
• Shares owned after the transactions: not specified in the provided data.
• Notable footnotes:
  • F1: Shares were withheld by the issuer to satisfy required income tax withholdings on RSU vesting/exercise.
  • F2–F5: Vesting schedules — one stock option vests 25% on Jan 22, 2027, then quarterly thereafter; RSUs vest in four equal annual installments beginning on specified dates (Jan 22, 2027; Jan 24, 2025; Jan 25, 2026) per the applicable grants.
• Filing: Reported on 2026-01-26 covering transactions from 2026-01-22 through 2026-01-25. Form 4s are generally due within two business days of a transaction; the 01-22 award appears reported four days later — review the official filing for any lateness notation.

Context

• These entries show option exercises and RSU awards, with shares withheld to cover tax obligations (a common administrative step). The exercises were reported with a $0.00 exercise price in the filing entries; the cash impact to the insider comes from taxes covered via share withholding (~$82.6K).
• Awards (RSUs) vest over multi-year schedules and do not indicate immediate sale or market sentiment by themselves. This filing is administrative in nature (exercises + tax withholding + multi-year RSU grants) rather than an open-market purchase or sale.